Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Richard K. Fuerstenberg"'
Autor:
Keith S. Bahjat, Alan J. Korman, Frances Rena Bahjat, Christina Milburn, Walter J. Urba, Brendan D. Curti, Richard K. Fuerstenberg, Michael D. Rynning, Shelly A. Bambina, Helena M. Hoen, Yoshinobu Koguchi
Treatment with ipilimumab improves overall survival (OS) in patients with metastatic melanoma. Because ipilimumab targets T lymphocytes and not the tumor itself, efficacy may be uniquely sensitive to immunomodulatory factors present at the time of tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbf81adbb03d29b4b3fd8e28d92b4ddf
https://doi.org/10.1158/0008-5472.c.6507456.v1
https://doi.org/10.1158/0008-5472.c.6507456.v1
Autor:
Keith S. Bahjat, Alan J. Korman, Frances Rena Bahjat, Christina Milburn, Walter J. Urba, Brendan D. Curti, Richard K. Fuerstenberg, Michael D. Rynning, Shelly A. Bambina, Helena M. Hoen, Yoshinobu Koguchi
Figure S1A. Kaplan-Meier plot of survival by CXCL11 group for gp100-treated melanoma patients Figure S1B. Kaplan-Meier plot of survival by CXCL11 group for ipilimumab-treated melanoma patients Figure S1C. Kaplan-Meier plot of survival by MICA group f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::617bee7b85c9743127e92ce5514fe940
https://doi.org/10.1158/0008-5472.22408083.v1
https://doi.org/10.1158/0008-5472.22408083.v1